The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $184.92

Today's change+0.09 +0.05%
Updated July 1 3:23 PM EDT. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $184.92

Today's change+0.09 +0.05%
Updated July 1 3:23 PM EDT. Delayed by at least 15 minutes.

Perrigo Company PLC up slightly

Perrigo Company PLC is up just (U.S.)$0.09 today to (U.S.)$184.92. Shares have lost 2.24% over the last five days, but have gained 10.62% over the last year to date. This security has outperformed the S&P 500 by 17.84% during the last year.

Key company metrics

  • Open(U.S.) $185.74
  • Previous close(U.S.) $184.83
  • High(U.S.) $188.79
  • Low(U.S.) $184.29
  • Bid / Ask(U.S.) $184.85 / (U.S.) $184.92
  • YTD % change+10.62%
  • Volume745,571
  • Average volume (10-day)1,155,022
  • Average volume (1-month)1,155,900
  • Average volume (3-month)2,129,827
  • 52-week range(U.S.) $135.00 to (U.S.) $215.73
  • Beta0.25
  • Trailing P/E122.90×
  • P/E 1 year forward24.16×
  • Forward PEG1.62×
  • Indicated annual dividend(U.S.) $0.50
  • Dividend yield0.27%
  • Trailing EPS(U.S.) $1.50
Updated July 1 3:23 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.44%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue1,0491,0729521,144
Total other revenue--------
Total revenue1,0491,0729521,144
Gross profit379384322416
Total cost of revenue670688630728
Total operating expense850897814947
Selling / general / administrative143144146170
Research & development35533738
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)112211
Other operating expenses, total--------
Operating income199175137198
Interest income (expense), net non-operating-43-31-26--
Gain (loss) on sale of assets--------
Other--------
Income before tax-10385109166
Income after tax-957096132
Income tax, total-8151234
Net income-957096132
Total adjustments to net income--------
Net income before extra. items-957096132
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-957096132
Inc. avail. to common incl. extra. items-957096132
Diluted net income-957096132
Dilution adjustment--------
Diluted weighted average shares141137134134
Diluted EPS excluding extraordinary itemsvalue per share-0.670.510.720.98
Dividends per sharevalue per share0.130.110.110.11
Diluted normalized EPSvalue per share-0.670.590.731.05